Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingmin Qian

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Ethnopharmacology|August 11, 2022
Metabolomics and integrated network pharmacology analysis reveal that ginkgolides act as potential active anticancer components by regulating one-carbon metabolismJunyao Zhou, Mingmin Qian, Chenxi Li, et al.
Frontiers in Immunology|August 29, 2022
Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapyLinfang Wu, Daquan Wang, Yanhua Chen, et al.
Journal of the American Society for Mass Spectrometry|April 3, 2025
Norm ISWSVR Enhanced Data Repeatability and Accuracy in Large-Scale Targeted Quantification MetabolomicsJinpeng Bai, Chenxi Li, Mingmin Qian, et al.
Journal of Oncology|February 24, 2023
IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and ChemoradiotherapyLinfang Wu, Yibo Gao, Daquan Wang, et al.
The Analyst|May 14, 2026
Quantitative metabolomics identifies prognostic biomarkers associated with NSCLC after chemoradiotherapyLeirui Yuan, Linfang Wu, Mingmin Qian, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Ethnopharmacology|August 11, 2022
Metabolomics and integrated network pharmacology analysis reveal that ginkgolides act as potential active anticancer components by regulating one-carbon metabolismJunyao Zhou, Mingmin Qian, Chenxi Li, et al.
Frontiers in Immunology|August 29, 2022
Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapyLinfang Wu, Daquan Wang, Yanhua Chen, et al.
Journal of the American Society for Mass Spectrometry|April 3, 2025
Norm ISWSVR Enhanced Data Repeatability and Accuracy in Large-Scale Targeted Quantification MetabolomicsJinpeng Bai, Chenxi Li, Mingmin Qian, et al.
Journal of Oncology|February 24, 2023
IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and ChemoradiotherapyLinfang Wu, Yibo Gao, Daquan Wang, et al.
The Analyst|May 14, 2026
Quantitative metabolomics identifies prognostic biomarkers associated with NSCLC after chemoradiotherapyLeirui Yuan, Linfang Wu, Mingmin Qian, et al.
Pageof 1